Specific antibody promotes opsonization and PMN-mediated killing of phagocytosis-resistant Enterococcus faecium

FEMS Immunology and Medical Microbiology

Volumn 28, Issue 4, 2000, Pages 291-299

  Rakita, Robert M ^a,b   Quan, Van C ^b   Jacques Palaz, Karen ^b   Singh, Kavindra V ^b   Arduino, Roberto C ^b   Mee, Mee ^b   Murray, Barbara E ^b  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Antibody; Complement; Enterococcus faecium; Neutrophil; Phagocytosis

Indexed keywords

ANTISERUM; COMPLEMENT; POLYCLONAL ANTIBODY;

ADSORPTION; ARTICLE; CELL KILLING; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; NEUTROPHIL; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; SERUM;

ANIMALS; ANTIBODIES, BACTERIAL; COMPLEMENT ACTIVATION; ENTEROCOCCUS FAECIUM; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; IMMUNE SERA; NEUTROPHILS; OPSONIN PROTEINS; PHAGOCYTOSIS; RABBITS;

EID: 0034097921     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(00)00169-3     Document Type: Article

References (42)

1. Murray B.E. The life and times of the Enterococcus. Clin. Microbiol. Rev. 3:1990;46-65.
2. Schaberg D.R., Culver D.H., Gaynes R.P. Major trends in the microbial etiology of nosocomial infection. Am. J. Med. 91:1991;72S-75S.
3. Leclercq R., Courvalin P. Resistance to glycopeptides in enterococci. Clin. Infect. Dis. 24:1997;545-556.
4. Murray B.E. Vancomycin-resistant enterococci. Am. J. Med. 102:1997;284-293.
5. Jones R.N., Marshall S.A., Pfaller M.A., Wilke W.W., Hollis R.J., Erwin M.E., Edmond M.B., Wenzel R.P. Nosocomial enterococcal blood stream infections in the SCOPE program: antimicrobial resistance, species occurrence, molecular testing, results, and laboratory testing accuracy. Diagn. Microbiol. Infect. Dis. 29:1997;95-102.
6. Clark N., Cooksey R., Hill B., Swenson J., Tenover F. Characterization of glycopeptide-resistant enterococci from US hospitals. Antimicrob. Agents Chemother. 37:1993;2311-2317.
7. Huycke M.M., Sahm D.F., Gilmore M.S. Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. Emerging Infect. Dis. 4:1998;239-249.
8. Arduino R.C., Murray B.E., Rakita R.M. Roles of antibodies and complement in phagocytic killing of Enterococci. Infect. Immun. 62:1994;987-993.
9. Harvey B.S., Baker C.J., Edwards M.S. Contributions of complement and immunoglobulin to neutrophil-mediated killing of enterococci. Infect. Immun. 60:1992;3635-3640.
10. Gaglani M.J., Baker C.J., Edwards M.S. Contribution of antibody to neutrophil-mediated killing of Enterococcus faecalis. J. Clin. Immunol. 17:1997;478-484.
11. Arduino R.C., Jacques-Palaz K., Murray B.E., Rakita R.M. Resistance of Enterococcus faecium to neutrophil-mediated phagocytosis. Infect. Immun. 62:1994;5587-5594.
12. Anderson D.C., Miller L.J., Schmalstieg F.C., Rothlein R., Springer T.A. Contributions of the Mac-1 glycoprotein family to adherence-dependent granulocytic functions: structure-function assessments employing subunit-specific monoclonal antibodies. J. Immunol. 137:1986;15-27.
13. Wallis W.J., Hickstein D.D., Schwartz B.R., June C.H., Ochs H.D., Beatty P.G., Klebanoff S.J., Harlan J.M. Monoclonal antibody-defined functional epitopes on the adhesion-promoting glycoprotein complex (CDw18) of human neutrophils. Blood. 67:1986;1007-1013.
14. Dana N., Styrt B., Griffin J.D., Todd R.F., Klempner M.S. III, Arnaout M.A. Two functional domains in the phagocyte membrane glycoprotein Mo1 identified with monoclonal antibodies. J. Immunol. 137:1986;3259-3263.
15. Entman M.L., Youker K., Shoji T., Kukielka G., Shappell S.B., Taylor A.A., Smith C.W. Neutrophil induced oxidative injury of cardiac myocytes. A compartmented system requiring CD11b/CD18-ICAM-1 adherence. J. Clin. Invest. 90:1992;1335-1345.
16. Barnstable C.J., Bodmer W.F., Brown G., Galfre G., Milstein C., Williams A.F., Ziegler A. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell. 14:1978;9-20.
17. Tausk F.A., McCutchan J.A., Spechko P., Schreiber R.D., Gigli I. Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome. J. Clin. Invest. 78:1986;977-982.
18. Miranda A.G., Singh K.V., Murray B.E. DNA fingerprinting of Enterococcus faecium by pulsed-field gel electrophoresis may be a useful epidemiologic tool. J. Clin. Microbiol. 29:1991;2752-2757.
19. Wessels M.R., Rubens C.E., Benedi V., Kasper D.L. Definition of a bacterial virulence factor: Sialylation of the group B streptococcal capsule. Proc. Natl. Acad. Sci. USA. 86:1989;8983-8987.
20. Wessels M.R., Paoletti L.C., Kasper D.L., DiFabio J.L., Michon F., Holme K., Jennings H.J. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus. J. Clin. Invest. 86:1990;1428-1433.
21. Dubois M.K., Gilles K.A., Hamilton J.K., Rebers P.A., Smith S. Colorimetric method for determination of sugars and related substances. Anal. Chem. 28:1956;350-356.
22. Hinson D.L., Webber R.J. Miniaturization of the BCA protein assay. BioTechniques. 6:1988;14-16.
23. Merkle R.K., Poppe I. Carbohydrate composition analysis of glycoconjugates by gas-liquid chromatography/mass spectrometry. Methods Enzymol. 230:1994;1-15.
24. Sulaiman A., Rakita R.M., Arduino R.C., Patterson J.E., Steckelberg J.M., Singh K.V., Murray B.E. Serology of enterococcal infections using Western blot. Eur. J. Clin. Microbiol. Infect. Dis. 15:1996;826-829.
25. Rosen H., Michel B.R., Chait A. Phagocytosis of opsonized oil droplets by neutrophils. J. Immunol. Methods. 144:1991;117-125.
26. Tan E.M., Kunkel H.G. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J. Immunol. 96:1966;464-471.
27. Pazur J.H., Cepure A., Kane J.A., Hellerquist C.G. Glycans from streptococcal cell walls: the molecular structure of an antigenic diheteroglycan of glucose and galactose from Streptococcus faecalis. J. Biol. Chem. 248:1973;279-284.
28. Pazur J.H. β-D-Glucose-1-phosphate: a structural unit and an immunological determinant of a glycan from streptococcal cell walls. J. Biol. Chem. 257:1982;589-591.
29. Smith C.L., Baker C.J., Anderson D.C., Edwards M.S. Role of complement receptors in opsonophagocytosis of Group B Streptococci by adult and neonatal neutrophils. J. Infect. Dis. 162:1990;489-495.
30. Diamond M.S., Garcia-Aguilar J., Bickford J.K., Corbi A.L., Springer T.A. The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands. J. Cell Biol. 120:1993;1031-1043.
31. Wright, S.D. (1992) Receptors for complement and the biology of phagocytosis. in: Inflammation: Basic Principles and Clinical Correlates, 2nd edn. (Gallin, J.I., Goldstein, I.M. and Snyderman, R., Eds.), pp. 477-495. Raven Press, New York.
32. Moffitt M., Frank M. Complement resistance in microbes. Springer Semin. Immunopathol. 15:1994;327-344.
33. Horstmann R.D. Target recognition failure by the nonspecific defense system: surface constituents of pathogens interfere with the alternative pathway of complement activation. Infect. Immun. 60:1992;721-727.
34. Edwards M.S., Kasper D.L., Jennings H.J., Baker C.J., Nicholson-Weller A. Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. J. Immunol. 128:1982;1278-1283.
35. Fearon D.T. Regulation by membrane sialic acid of b1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway. Proc. Natl. Acad. Sci. USA. 75:1978;1971-1975.
36. Edwards M.S., Nicholson-Weller A., Baker C.J., Kasper D.L. The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus. J. Exp. Med. 151:1980;1275-1287.
37. Ratnoff W.D., Fearon D.T., Austen K.F. The role of antibody in the activation of the alternative complement pathway. Springer Semin. Immunopathol. 6:1983;361-371.
38. 2-fragment of pepsin-treated rabbit antibody. Immunology. 20:1971;649-658.
39. Winkelstein J.A., Shin H.S. The role of immunoglobulin in the interaction of pneumococci and the properdin pathway: evidence for its specificity and lack of requirement for the Fc portion of the molecule. J. Immunol. 112:1974;1635-1642.
40. Trautmann M., Triest K., Hofstaetter T., Seiler F.R., Hahn H. Influence of different immunoglobulin G preparations on phagocytosis of Pseudomonas aeruginosa by polymorphonuclear granulocytes. Zbl. Bakteriol. Hyg. A. 259:1985;104-117.
41. 2 fragment for activation of the complement system through the alternative pathway - I. disulfide bonds. Mol. Immunol. 18:1981;925-934.
42. Ehrnst A. Separate pathways of C activation by measles virus cytotoxic antibodies: subclass analysis and capacity of F(ab) molecules to activate C via the alternative pathway. J. Immunol. 121:1978;1206-1212.